155 related articles for article (PubMed ID: 23721813)
1. Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice.
Zhang QS; Watanabe-Smith K; Schubert K; Major A; Sheehan AM; Marquez-Loza L; Newell AE; Benedetti E; Joseph E; Olson S; Grompe M
Stem Cell Res; 2013 Sep; 11(2):687-92. PubMed ID: 23721813
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.
Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J
Cell Stem Cell; 2012 Jul; 11(1):36-49. PubMed ID: 22683204
[TBL] [Abstract][Full Text] [Related]
3. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
[TBL] [Abstract][Full Text] [Related]
4. Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2
Yoon YM; Storm KJ; Kamimae-Lanning AN; Goloviznina NA; Kurre P
Stem Cell Reports; 2016 Nov; 7(5):840-853. PubMed ID: 27720904
[TBL] [Abstract][Full Text] [Related]
5. Fancd2-deficient hematopoietic stem and progenitor cells depend on augmented mitochondrial translation for survival and proliferation.
Chatla S; Du W; Wilson AF; Meetei AR; Pang Q
Stem Cell Res; 2019 Oct; 40():101550. PubMed ID: 31472450
[TBL] [Abstract][Full Text] [Related]
6. Fancd2 is required for nuclear retention of Foxo3a in hematopoietic stem cell maintenance.
Li X; Li J; Wilson A; Sipple J; Schick J; Pang Q
J Biol Chem; 2015 Jan; 290(5):2715-27. PubMed ID: 25505262
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.
Parmar K; Kim J; Sykes SM; Shimamura A; Stuckert P; Zhu K; Hamilton A; Deloach MK; Kutok JL; Akashi K; Gilliland DG; D'andrea A
Stem Cells; 2010 Jul; 28(7):1186-95. PubMed ID: 20506303
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
[TBL] [Abstract][Full Text] [Related]
9. Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.
Li X; Wilson AF; Du W; Pang Q
Stem Cell Reports; 2018 Feb; 10(2):339-346. PubMed ID: 29307578
[TBL] [Abstract][Full Text] [Related]
10. Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
Zhang QS; Marquez-Loza L; Eaton L; Duncan AW; Goldman DC; Anur P; Watanabe-Smith K; Rathbun RK; Fleming WH; Bagby GC; Grompe M
Blood; 2010 Dec; 116(24):5140-8. PubMed ID: 20826722
[TBL] [Abstract][Full Text] [Related]
11. Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathway in vivo.
Yang Y; Poe JC; Yang L; Fedoriw A; Desai S; Magnuson T; Li Z; Fedoriw Y; Araki K; Gao Y; Tateishi S; Sarantopoulos S; Vaziri C
Nucleic Acids Res; 2016 May; 44(9):4174-88. PubMed ID: 26883629
[TBL] [Abstract][Full Text] [Related]
12. Severe Fanconi Anemia phenotypes in Fancd2 depletion mice.
Yang Q; Xie H; Zhong Y; Li D; Ke X; Ying H; Yu B; Zhang T
Biochem Biophys Res Commun; 2019 Jun; 514(3):713-719. PubMed ID: 31078270
[TBL] [Abstract][Full Text] [Related]
13. Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures.
Zhang X; Hou W; Epperly MW; Rigatti L; Wang H; Franicola D; Sivanathan A; Greenberger JS
Oncotarget; 2016 Oct; 7(42):68449-68472. PubMed ID: 27637088
[TBL] [Abstract][Full Text] [Related]
14. Damage control and its costs: BM failure in Fanconi anemia stems from overactive p53/p21.
Dumitriu B; Young NS
Cell Stem Cell; 2012 Jul; 11(1):7-8. PubMed ID: 22770237
[TBL] [Abstract][Full Text] [Related]
15. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.
Garaycoechea JI; Crossan GP; Langevin F; Daly M; Arends MJ; Patel KJ
Nature; 2012 Sep; 489(7417):571-5. PubMed ID: 22922648
[TBL] [Abstract][Full Text] [Related]
16. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
[TBL] [Abstract][Full Text] [Related]
17. The ATM/p53/p21 pathway influences cell fate decision between apoptosis and senescence in reoxygenated hematopoietic progenitor cells.
Zhang X; Li J; Sejas DP; Pang Q
J Biol Chem; 2005 May; 280(20):19635-40. PubMed ID: 15753076
[TBL] [Abstract][Full Text] [Related]
18. Impairment of fetal hematopoietic stem cell function in the absence of Fancd2.
Suzuki S; Racine RR; Manalo NA; Cantor SB; Raffel GD
Exp Hematol; 2017 Apr; 48():79-86. PubMed ID: 27915139
[TBL] [Abstract][Full Text] [Related]
19. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.
Amarachintha S; Sertorio M; Wilson A; Li X; Pang Q
Stem Cells; 2015 Nov; 33(11):3382-96. PubMed ID: 26212365
[TBL] [Abstract][Full Text] [Related]
20. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
